Your browser doesn't support javascript.
loading
Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada.
Hsu, Sylvia H; Chang, Su-Hsin; Gross, Cary P; Wang, Shi-Yi.
Afiliação
  • Hsu SH; Schulich School of Business, York University, Toronto, Ontario, Canada.
  • Chang SH; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Gross CP; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Wang SY; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA; Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA. Electronic address: sh
Int J Infect Dis ; 109: 189-191, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34216734
ABSTRACT

OBJECTIVES:

To examine whether the case fatality rate (CFR) of COVID-19 decreased over time and whether the COVID-19 testing rate is a driving factor for the changes if the CFR decreased.

METHODS:

Analyzing COVID-19 cases, deaths and tests in Ontario, Canada, we compared the CFR between the first wave and the second wave across 26 public health units in Ontario. We also explored whether a high testing rate was associated with a large CFR decrease.

RESULTS:

The first wave CFR ranged from 0.004 to 0.146, whereas the second wave CFR ranged from 0.003 to 0.034. The pooled RR estimate of second wave COVID-19 case fatality, compared with first wave, was 0.24 (95% CI 0.19-0.32). Additionally, COVID-19 testing percentages were not associated with the estimated relative risk (P=0.246).

CONCLUSIONS:

The COVID-19 CFR decreased significantly in Ontario during the second wave, and COVID-19 testing was not a driving factor for this decrease.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Int J Infect Dis Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Int J Infect Dis Ano de publicação: 2021 Tipo de documento: Article